THERATEST EL-ANTI-CCP/2

Antibodies, Anti-cyclic Citrullinated Peptide (ccp)

THERATEST LABORATORIES, INC.

The following data is part of a premarket notification filed by Theratest Laboratories, Inc. with the FDA for Theratest El-anti-ccp/2.

Pre-market Notification Details

Device IDK090753
510k NumberK090753
Device Name:THERATEST EL-ANTI-CCP/2
ClassificationAntibodies, Anti-cyclic Citrullinated Peptide (ccp)
Applicant THERATEST LABORATORIES, INC. 1111 N. MAIN ST. Lombard,  IL  60148
ContactMarius Teodorescu
CorrespondentMarius Teodorescu
THERATEST LABORATORIES, INC. 1111 N. MAIN ST. Lombard,  IL  60148
Product CodeNHX  
CFR Regulation Number866.5775 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2009-03-20
Decision Date2010-03-05
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00854473003019 K090753 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.